Trillat A C, Malagié I, Bourin M, Jacquot C, Hen R, Gardier A M
Laboratoire de Neuropharmacologie EAD MESR 98-213, Faculté de Pharmacie, Université Paris-Sud, Châtenay-Malabry, France.
C R Seances Soc Biol Fil. 1998;192(6):1139-47.
We use the knockout mice strategy to investigate the contribution of the 5-HT1B receptor in mediating the effects of selective serotonin reuptake inhibitors (SSRI). Using microdialysis in awake 129/Sv mice, we show that the absence of the 5-HT1B receptor in mutant mice (KO 1B -/-) potentiated the effect of paroxetine on extracellular 5-HT levels in the ventral hippocampus, but not in the frontal cortex compared to wild-type mice (WT). Furthermore, using the forced swimming test, we demonstrate that SSRIs decreased immobility of WT mice, and this effect is absent in KO 1B -/- mice showing therefore that activation of 5-HT1B receptors mediate the antidepressant-like effects of SSRIs. Taken together these findings suggest that 5-HT1B autoreceptors limit the effects of SSRI particularly in the hippocampus while postsynaptic 5-HT1B receptors are required for the antidepressant activity of SSRIs.
我们采用基因敲除小鼠策略来研究5-羟色胺1B受体(5-HT1B受体)在介导选择性5-羟色胺再摄取抑制剂(SSRI)作用中的贡献。通过对清醒的129/Sv小鼠进行微透析,我们发现与野生型小鼠(WT)相比,突变小鼠(KO 1B -/-)中5-HT1B受体的缺失增强了帕罗西汀对腹侧海马体而非额叶皮质细胞外5-羟色胺水平的影响。此外,通过强迫游泳试验,我们证明SSRI降低了WT小鼠的不动时间,而在KO 1B -/-小鼠中这种作用不存在,因此表明5-HT1B受体的激活介导了SSRI的抗抑郁样作用。综合这些发现表明,5-HT1B自身受体限制了SSRI的作用,特别是在海马体中,而突触后5-HT1B受体是SSRI发挥抗抑郁活性所必需的。